Home Life Sciences PAQR6 expression enhancement suggests a worse prognosis in prostate cancer patients
Article Open Access

PAQR6 expression enhancement suggests a worse prognosis in prostate cancer patients

  • , , , and EMAIL logo
Published/Copyright: December 31, 2018
Download Article (PDF)
Open Life Sciences
From the journal Open Life Sciences Volume 13 Issue 1

Abstract

Objective

This study aimed to evaluate the expression of progestin and adipoQ receptor family member VI (PAQR6, mPRδ) in prostate cancer and to explore its role in prostate cancer progression.

Methods

PAQR6 mRNA expression was evaluated based on the data obtained from the TCGA database and the GEO database. The prognostic value of PAQR6 was explored by Kaplan-Meier analysis. To investigate the role of PAQR6, it was depleted by siRNA in DU145 cells. The effects of depleting PAQR6 on DU145 cell viability and migration were determined by CCK8 assay, colony formation assay, and wound healing assay, respectively. The activation of MEK and ERK were analyzed by western blot.

Results

PAQR6 mRNA expression was significantly up-regulated in prostate cancer tissues and correlated with lower survival rates (p=0.014). Furthermore, qPCR revealed that PAQR6 expression was elevated in DU145 and LNCaP cells compared with RWPE-2 cells. Depleting PAQR6 obviously suppressed DU145 cell proliferation and migration (p<0.01). In addition, the ratio of p-MEK/MEK and p-ERK/ERK was significantly reduced after silencing PAQR6 (p<0.01).

Conclusion

PAQR6 might play a facilitating role in prostate cancer development by regulating the MAPK signaling pathway. Moreover, it might serve as a potential predictor and therapeutic target in prostate cancer.

Keywords: PAQR6; Kaplan-Meier analysis; proliferation; migration; MAPK signaling pathway

1 Introduction

Prostate cancer is one of the most common malignancies in the male genitourinary system as well as a leading cause of cancer-related death in developed countries [1, 2]. The high incidence of prostate cancer is related to many factors such as age, ethnicity, family history, and genetic susceptibility [3]. Although some progress has been made in the pathogenesis, detection, and therapy of prostate cancer during the past years, metastasis of the lesion and the risk of recurrence after surgery remain major problems [4]. Hence, finding effective prognostic and diagnostic biomarkers and therapeutic targets is of great significance for the treatment of prostate cancer.

Progesterone, one of the sex steroid hormones, possibly acts through multiple receptors and has been reported to be involved in many cell biology process (proliferation, differentiation, etc.) as well as in the progression of various cancers [5, 6] . It has been found that high progesterone receptor (PGR) density is an independent poor prognostic factor in prostate cancer [5]. Membrane progesterone receptors (mPRs) that belong to the progestin and adipoQ receptor (PAQR) family are putative non-classical progesterone signaling molecules [7, 8, 9]. To date, five of these molecules have been identified in humans: PAQR5 (mPRγ), PAQR6 (mPRδ), PAQR7 (mPRα), PAQR8 (mPRβ), and PAQR9 (mPRε) [10]. Differential expression of PAQR5 and PAQR8 was found in ovarian cystadenomas, borderline tumors, and carcinomas, suggesting that they have important roles in epithelial ovarian tumors [11]. PAQR5 and PAQR8 were also supposed to be potential prognostic biomarkers of endometrial cancer [10]. In human glioblastoma cells, the activation of PAQR7 has been found to exhibit a promoting effect on cell proliferation and motility, implying its involvement in glioblastoma development [12]. In addition, LI ZHOU et al. found that progesterone inhibits triple-negative breast cancer growth and metastasis via PAQR7 [13]. This evidence suggests that mPRs play an important role in cancer development and have the potential to be therapy targets and biomarkers in cancer.

Here, we first analyzed the expression of PAQR6 in prostate cancer tissues based on data obtained from the public database. Then the role of PAQR6 in prostate cancer cell growth and migration was investigated by depleting PAQR6 using siRNA. Our observation demonstrated for the first time that PAQR6 expression is elevated in prostate cancer and plays a facilitating role in prostate cancer progression.

2 Methods

2.1 Data collection

The expression data of 13 malignant prostate tissue samples and 8 benign prostate tissue samples were obtained from Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) database with the access number of GSE55945. The RNA-Seq expression data of 499 prostate cancer samples and 52 normal samples were downloaded from the TCGA database (https://cancergenome.nih.gov/) Moreover, the clinic-data of these 499 prostate cancer patients were downloaded together.

2.2 Cell culture

The human normal prostate epithelial cell line RWPE-2 was obtained from American Type Culture Collection (ATCC, USA) and cultured in Keratinocyte Serum Free Medium (K-SFM) supplemented with 0.05 mg/ml bovine pituitary extract (BPE) and 5 ng/ml epidermal growth factor (EGF). The prostate cancer cell lines DU145 and LNCaP were purchased from the Chinese Academy of Sciences Shanghai Academy of Sciences Cell Resource Center (Shanghai, China). DU145 cells were cultured in MEM medium supplemented with 10% fetal bovine serum (FBS; HyClone: Logan, UT). LNCaP cells were grown in RPMI-1640 medium (Corning: Manassas, VA) supplemented with 10% FBS. All the cells were cultivated at 37°C with 5% CO2

2.3 Transfection

Transfections with PAQR6 and scrambled small interfering RNA (siRNA) were executed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) in line with the description of the specification. The PAQR6 siRNAs (PAQR6 siRNA1: 5’-GCUGCCCCAACUUCUUCAA-3’ and siRNA2: 5’-CAUCUGGACUCACUU CCUG-3’) and scrambled siRNA (5’-CUUCUUCAACCGUCGCCAA-3’) were all purchased from GENEWIZ, Inc. (Beijing, China). After 6 h of culture, the transfection medium was replaced with complete medium and incubated for 48 h. Following that, the cells were subjected to the following experiments.

2.4 RNA extraction and real-time quantitative PCR

Total RNA of prostate cancer cell lines was isolated using RNAiso Plus (TaKaRa Biotechnology, Dalian, China) following the manufacturer’s protocol. Synthesis of cDNA using RNA as a template was conducted with the HiFiScript cDNA Synthesis Kit (CwBio, Beijing, China). The mRNA expression level of PAQR6 was determined by reverse transcription polymerase chain reaction (RT-PCR) using the Applied Biosystems 7300 Sequence Detection System (Applied Biosystems). The following primers for PAQR6 were used: forward: 5’-GGTGTTCTGGGAAGATGGCA-3’ and reverse: 5’-TCTGGAAGGAGCTGAGGACA-3’. GAPDH (forward: 5’-GGAGCGAGATCCCTCCAAAAT-3’; reverse: 5’-GGCTGTTGTCATACTTCTCATGG-3’) was used as the endogenous reference gene. The PAQR6 mRNA expression was calculated using a 2-ΔΔCt method.

2.5 Cell proliferation assay

Cell Counting Kit-8 (CCK8, Dojindo, Kumamoto, Japan) was used to examine the effect of silencing of PAQR6 by siRNA on prostate cancer cell proliferation. Cells after 48 h of transfection were seeded into 96-well plates (1000 cells/well) and cultured at 37°C with 5% CO2. Cell viability was measured with CCK8 according to the manufacturer’s protocol at the time points of 24 h, 48 h, 72 h, and 96 h of incubation. The absorbance at 450 nm was determined using a microplate reader. All experiments were performed in triplicate and done at least 3 independent times.

2.6 Colony formation assay

Single cell suspensions were prepared and plated onto fresh 60 mm dishes (700 cells/dish). The cells were cultured in media with 10% FBS for 2 weeks. During these 2 weeks, the medium was replaced with fresh media every 4 days. The colonies were fixed by methanol and stained with 0.1% crystal violet. The visible colonies were counted, and the relative ratio of colonies was calculated by considering the colony number of the si-con group as 100%.

2.7 Wound healing assay

For the purpose of investigating the effect of PAQR6 knockdown on DU145 cell migration, we implemented a wound healing assay. A micropipette tip was used to make a horizontal wound in the cell monolayer. The width of the wounds was photographed and measured 0 h and 24 h post scratching. The relative migration distance of DU145 cells with silenced PAQR6 was calculated by considering the migration distance of the control DU145 cells (si-con) as 100%.

2.8 Western blot analysis

Total protein of prostate cancer cells was extracted using RIPA lysis buffer (Beyotime, Jiangsu, China) and measured using the BCA method. Then the proteins were fractionated by 10% SDS-PAGE and electrotransferred to a PVDF membrane (Millipore, Bedford, MA) followed by blocking with 5% skim milk for 1 h at room temperature. Subsequently, the membranes were incubated with rabbit anti-human primary antibodies at 4°C for 16 h. Then the membranes were incubated with secondary antibodies (1/1000, Cell Signaling Technology) at room temperature for 1 h. Lastly, the signals were detected using an Enhanced chemi-luminescence (ECL) plus detection kit (Thermo Fisher Scientifc, Inc.). The expression of GAPDH was used as an internal control.

2.9 Statistical analysis

Kaplan-Meier analysis and log-rank tests were performed to draw the survival curve and assess the difference between groups. The samples were divided into high and low expression groups according to the median of PAQR6 expression. Statistical analysis was performed using SPSS 15.0 software. One-way ANOVA analysis was used to compare the mean of multiple samples. It was considered as statistically significant when p<0.05.

Ethical approval: The conducted research is not related to either human or animals use.

3 Results

3.1 PAQR6 mRNA expression was enhanced in prostate cancer tissues and associated with poor prognosis

We investigated the relative PAQR6 mRNA expression level in prostate cancer tissues (n=499) compared with normal prostate tissues (n=52) based on the data downloaded from the TCGA database. Our results showed that PAQR6 mRNA expression was obviously up-regulated in prostate cancer tissues compared with normal prostate tissues (p=1.29E-22, Figure 1A). Based on the data obtained from the GEO database, the up-regulation of PAQR6 was also observed in malignant prostate tissue (n=13) compared with benign prostate tissue (n=8, p=0.001687, Figure 1B).

Figure 1 The mRNA expression level of PAQR6 was up-regulated in prostate cancer and positively related to poor prognosis in prostate cancer patients. (A) Analysis of PAQR6 mRNA expression in prostate cancer samples (N=499) and normal prostate samples (N=52) based on the expression profile downloaded from the TCGA database. (B) Analysis of PAQR6 mRNA expression in malignant prostate tissues (N=13) and benign prostate tissues (N=8) based on the expression profile obtained from the GEO database with access number GSE55945. (C) The correlation between PAQR6 expression and overall survival time was analyzed using Kaplan-Meier method based on the TCGA database. The samples were divided into high PAQR6 expression (N=250) and low PAQR6 expression (N=249) according the median of PAQR6 mRNA expression.
Figure 1

The mRNA expression level of PAQR6 was up-regulated in prostate cancer and positively related to poor prognosis in prostate cancer patients. (A) Analysis of PAQR6 mRNA expression in prostate cancer samples (N=499) and normal prostate samples (N=52) based on the expression profile downloaded from the TCGA database. (B) Analysis of PAQR6 mRNA expression in malignant prostate tissues (N=13) and benign prostate tissues (N=8) based on the expression profile obtained from the GEO database with access number GSE55945. (C) The correlation between PAQR6 expression and overall survival time was analyzed using Kaplan-Meier method based on the TCGA database. The samples were divided into high PAQR6 expression (N=250) and low PAQR6 expression (N=249) according the median of PAQR6 mRNA expression.

The Kaplan-Meier analysis demonstrated that PAQR6 expression was a potential predictor of survival. Patients with higher PAQR6 mRNA expression presented a shorter survival time compared to those with lower expression (p=0.014, Figure 1C).

3.2 Silencing PAQR6 inhibits DU145 cell proliferation

To further explore the role of PAQR6 in prostate cancer progression, we explored the mRNA expression of PAQR6 in prostate cancer cell lines by qPCR. Our results showed that PAQR6 mRNA expression levels in DU145 and LNCaP cells were remarkably higher than in RWPE-2 cells (p<0.01, Figure 2A). Since the DU145 cell line showed the highest PAQR6 levels, it was used for subsequent experiments. Si- PAQR6 (1) and si- PAQR6 (2) were synthesized and transfected into DU145 cells to deplete PAQR6 expression. As shown in Figure 2B, PAQR6 mRNA expression was down-regulated to 36.7% and 15.2% by using si- PAQR6 (1) and si- PAQR6 (2), respectively. Western blot analysis showed similar down regulation of PAQR6 protein levels (p<0.01, Figure 2C-D). Subsequent CCK8 assays showed that the OD value of the si- PAQR6 group was significantly lower at 48 h, 72 h, and 96 h compared to that of the si-con group (p<0.01, Figure 3A). The results of the colony formation assay were consistent with the outcomes observed in the CCK8 assay. We found that the number of colonies formed in the si- PAQR6 group was significantly smaller than that of the si-con group (p<0.01, Figure 3 B-C). These data suggest that down-regulating PAQR6 significantly inhibits cell proliferation.

Figure 2 Knockdown of PAQR6 by PAQR6 siRNA in prostate cancer cells. (A) The mRNA expression levels of PAQR6 in prostate cancer cell lines DU145 and LNCaP as well as normal RWPE-2 cells line were determined by qPCR. (B) The mRNA expression levels of PAQR6 in DU145 cells were analyzed by qPCR 48 h after transfection. (C) PAQR6 protein expression in DU145 cells was determined by western blot 48 h after transfection. (D) Quantification of PAQR6 protein expression. Columns, mean (n= 6); bars, SD. **P<0.01, vs. PAQR6 expression in DU145 cells transfected with scramble siRNA (si-con).
Figure 2

Knockdown of PAQR6 by PAQR6 siRNA in prostate cancer cells. (A) The mRNA expression levels of PAQR6 in prostate cancer cell lines DU145 and LNCaP as well as normal RWPE-2 cells line were determined by qPCR. (B) The mRNA expression levels of PAQR6 in DU145 cells were analyzed by qPCR 48 h after transfection. (C) PAQR6 protein expression in DU145 cells was determined by western blot 48 h after transfection. (D) Quantification of PAQR6 protein expression. Columns, mean (n= 6); bars, SD. **P<0.01, vs. PAQR6 expression in DU145 cells transfected with scramble siRNA (si-con).

Figure 3 Depletion of PAQR6 inhibits DU145 cell proliferation. DU145 cell proliferation ability was determined by CCK8 assay 48 h after transfection. (B) DU145 cell proliferation ability was determined by colony formation assay. (C) The relative ratio of colonies in Figure (B). N=6. **P<0.01, vs. DU145 cells transfected with scramble siRNA (si-con).
Figure 3

Depletion of PAQR6 inhibits DU145 cell proliferation. DU145 cell proliferation ability was determined by CCK8 assay 48 h after transfection. (B) DU145 cell proliferation ability was determined by colony formation assay. (C) The relative ratio of colonies in Figure (B). N=6. **P<0.01, vs. DU145 cells transfected with scramble siRNA (si-con).

3.3 Silencing PAQR6 inhibits DU145 cell migration

Wound healing assays were performed to determine the migration ability of DU145 cells. We found that knockdown of PAQR6 significantly reduced the migration distance to 47% of that observed in the cells transfected with scrambled siRNA (Figure 4 A-B, p<0.01). These results demonstrated that DU145 cell migration ability was markedly suppressed after depleting PAQR6.

Figure 4 Knockdown of PAQR6 suppressed DU145 cell migration. (A) The effects of silencing PAQR6 on DU145 cell migration were determined by wound healing assays 0 h and 24 h after scratching. The bar represents 200 μm. (B) The relative migration distance of DU145. **p<0.01, vs. DU145 cells transfected with scramble control siRNA (si-con).
Figure 4

Knockdown of PAQR6 suppressed DU145 cell migration. (A) The effects of silencing PAQR6 on DU145 cell migration were determined by wound healing assays 0 h and 24 h after scratching. The bar represents 200 μm. (B) The relative migration distance of DU145. **p<0.01, vs. DU145 cells transfected with scramble control siRNA (si-con).

3.4 Silencing PAQR6 inhibits the MAPK signaling pathway

To study the potential mechanistic role of PAQR6 in cell proliferation and migration, we examined the expression changes of MAPK-related proteins in DU145 cells 8 h after transfection by western blot. Our results showed that the ratio of p-MEK/MEK and p-ERK/ERK was significantly reduced in PAQR6-depleted DU145 cells compared with cells transfected with scrambled siRNA (Figure 5 A-B, p<0.01). These results suggested that silencing PAQR6 remarkably suppresses activation of the MAPK signaling pathway.

Figure 5 Knockdown of PAQR6 significantly suppressed the activation of the MAPK signaling pathway. (A) The protein expression of p-MEK, MEK, p-ERK, and ERK in DU145 cells was determined by western blot. (B) Quantification of the ratio of p-MEK/MEK, p-ERK/ERK obtained by western blot. Columns, mean (n= 6); bars, SD. **P<0.01, vs. expression of these proteins in DU145 cells transfected with scramble siRNA (si-con).
Figure 5

Knockdown of PAQR6 significantly suppressed the activation of the MAPK signaling pathway. (A) The protein expression of p-MEK, MEK, p-ERK, and ERK in DU145 cells was determined by western blot. (B) Quantification of the ratio of p-MEK/MEK, p-ERK/ERK obtained by western blot. Columns, mean (n= 6); bars, SD. **P<0.01, vs. expression of these proteins in DU145 cells transfected with scramble siRNA (si-con).

4 Discussion

In the present study, we observed that PAQR6 is up-regulated in prostate cancer tissues and that high expression of PAQR6 is correlated with lower overall survival rate. Through a series of in vitro experiments, we demonstrated that PAQR6 might play a facilitating role in prostate cancer cell proliferation and migration by regulating the MAPK signaling pathway.

PAQR6, a member of the PAQR family, has been characterized to be capable of responding to progesterone and suggested to possess progestin-binding characteristics [14, 15]. It is considered to be a unique type of G protein-coupled receptor that acts via cAMP in the nervous system [16]. Previous studies showed that PAQR6 is highly expressed in the human brain [17] and also in the small intestine and back fat of swine [15]. However, the expression and the function of this gene, particularly in prostate cancer, remains unclear.

In this study, we analyzed the PAQR6 mRNA expression in prostate cancer tissues based on the TCGA database and the GEO database. Our results indicated that PAQR6 mRNA expression was enhanced in prostate cancer tissues compared with normal tissues (Figure 1 A-B). The up-regulation of PAQR6 was also observed in prostate cancer cell lines DU145 and LNCaP compared with normal RWPE-2 cells (Figure 2A). Further prognostic analysis revealed that higher PAQR6 expression was closely associated with poor prognosis in prostate cancer patients (p=0.014, Figure 1C). These data suggest that PAQR6 might promote prostate cancer development and can be used as a potential independent prognostic marker.

In order to further investigate the role of PAQR6 in prostate cancer, we performed a knockdown of this gene in DU145 cells using si-PAQR6 (Figure 2B-D). Our results showed that DU145 expression was significantly down-regulated after transfection with si- PAQR6. It is well known that excessive proliferation is one of the main features of cancer cells. Therefore, we then examined the proliferation ability of DU145 cells following the depletion of PAQR6 using CCK8 assays and colony formation assays. Our results demonstrated that the viability of DU145 cells decreased significantly after silencing PAQR6 (p<0.01 Figure 3), suggesting that PAQR6 might promote the proliferation of prostate cancer cells. Another characteristic of cancer cells is that invasion and migration are often activated [18]. Hence, we performed a wound healing assay and found that the migration distance of DU145 cells with silenced PAQR6 was shorter compared with the si-con group (p<0.01, Figure 4). This phenomenon indicated that PAQR6 might promote cell migration in vitro. In summary, our results revealed that PAQR6 possibly acts as a pro-tumor factor in prostate cancer occurrence and progression.

MAPK signaling pathway is known as an important downstream signaling cascade in several biological events as well as various types of cancers [19, 20]. It is essential for the transcription of genes participating in cell growth and survival [20, 21]. Hence, we next studied the effect of silencing PAQR6 on the expression of MAPK signaling pathway related proteins by western blot. Our results demonstrated that the ratio of p-MEK/MEK and p-ERK/ERK decreased remarkably after silencing PAQR6 (p<0.01, Figure 5). We conjectured that PAQR6 may inhibit cell proliferation and migration by modulating the MAPK signaling pathway.

Taken together, our results demonstrate for the first time that PAQR6 expression is enhanced in prostate cancer tissues and positively associated with poor prognosis in prostate cancer patients. In addition, PAQR6 might act as a tumor promoter by regulating the MAPK signaling pathway and might be a new therapeutic target for prostate cancer. However, the promoting role of this gene in the cancer development process needs to be further validated in animal models as soon as possible.

Fax: +8675783812566

Acknowledgements

The authors are grateful for the help of Yue-Jian Wang.

  1. Conflict of interest: Authors state no conflict of interest.

References

[1] Ramalho-Carvalho J, Gonçalves C, Graça I, Bidarra D, Pereira-Silva E, Salta S, et al. A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting, Clin Epigenetics, 2018;10: 40.10.1186/s13148-018-0475-2Search in Google Scholar PubMed PubMed Central

[2] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016, CA: a cancer journal for clinicians, 2016;66:7-30.10.3322/caac.21332Search in Google Scholar PubMed

[3] Cancer Genome Atlas Research N. The Molecular Taxonomy of Primary Prostate Cancer, Cell, 2015;163:1011-1025.10.1016/j.cell.2015.10.025Search in Google Scholar PubMed PubMed Central

[4] Zoni E, Van dHG, Af VDM, Chen L, Rane JK, Pelger RC, et al. miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression, Cancer Research, 2015;75:2326-2336.10.1158/0008-5472.CAN-14-2155Search in Google Scholar PubMed

[5] Grindstad T, Andersen S, Al-Saad S, Donnem T, Kiselev Y, Nordahl M-JC, et al. High progesterone receptor expression in prostate cancer is associated with clinical failure, PloS one, 2015;10:e0116691.10.1371/journal.pone.0116691Search in Google Scholar PubMed PubMed Central

[6] Migliaccio A, Castoria G, Auricchio F. Src-dependent signalling pathway regulation by sex-steroid hormones: therapeutic implications, International Journal of Biochemistry & Cell Biology, 2007;39:1343-1348.10.1016/j.biocel.2006.12.009Search in Google Scholar PubMed

[7] Petersen SL, Intlekofer KA, Mouraconlon PJ, Brewer DN, Sans JDP, Lopez JA. Novel progesterone receptors: neural localization and possible functions, Frontiers in Neuroscience, 2013;7:164.10.3389/fnins.2013.00164Search in Google Scholar PubMed PubMed Central

[8] Jia CY, Li HH, Zhu XC, Dong YW, Fu D, Zhao QL, et al. MiR-223 suppresses cell proliferation by targeting IGF-1R, PLoS One, 2011;6:e27008.10.1371/journal.pone.0027008Search in Google Scholar PubMed PubMed Central

[9] Valadezcosmes P, Vázquezmartínez ER, Cerbón M, Camachoarroyo I. Membrane progesterone receptors in reproduction and cancer, Mol. Cell. Endocrinol., 2016;434:166-175.10.1016/j.mce.2016.06.027Search in Google Scholar PubMed

[10] Sinreih M, Knific T, Thomas P, Grazio SF, Rižner TL. Membrane progesterone receptors β and γ have potential as prognostic biomarkers of endometrial cancer, J. Steroid Biochem. Mol. Biol., 2018:17810.1016/j.jsbmb.2018.01.011Search in Google Scholar PubMed

[11] Romero-Sánchez M, Peiper S, Evans B, Wang Z, Catasús L, Ribe A, et al. Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors, Hum. Pathol., 2008;39:1026-1033.10.1016/j.humpath.2007.11.007Search in Google Scholar

[12] González-Orozco JC, Hansberg-Pastor V, Valadez-Cosmes P, Nicolas-Ortega W, Bastida-Beristain Y, Fuente-Granada MDL, et al. Activation of membrane progesterone receptor-alpha increases proliferation, migration, and invasion of human glioblastoma cells, Mol. Cell. Endocrinol., 2018.10.1016/j.mce.2018.06.004Search in Google Scholar PubMed

[13] Li Z, Wei Z, Zhang H, Yan H, Lei Y, Zhang Y, et al. Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor α, Int. J. Mol. Med., 2017;40:755-761.10.3892/ijmm.2017.3060Search in Google Scholar PubMed PubMed Central

[14] Smith JL, Kupchak BR, Garitaonandia I, Hoang LK, Maina AS, Regalla LM, et al. Heterologous expression of human mPRα, mPRβ and mPRγ in yeast confirms their ability to function as membrane progesterone receptors, Steroids, 2008;73:1160-1173.10.1016/j.steroids.2008.05.003Search in Google Scholar PubMed PubMed Central

[15] Zhao X, Mo D, Li A, Gong W, Zhang Y, Qian W, et al. Characterization and transcriptional regulation analysis of the porcine PAQR6 gene, DNA Cell Biol., 2011;30:947.10.1089/dna.2011.1262Search in Google Scholar PubMed

[16] Thomas P, Pang Y. Membrane progesterone receptors: evidence for neuroprotective, neurosteroid signaling and neuroendocrine functions in neuronal cells, Neuroendocrinology, 2012;96:162-171.10.1159/000339822Search in Google Scholar PubMed PubMed Central

[17] Tang YT, Hu T, Arterburn M, Boyle B, Bright JM, Emtage PC, et al. PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif, J. Mol. Evol., 2005;61:372-380.10.1007/s00239-004-0375-2Search in Google Scholar PubMed

[18] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation, Cell 2011;144:646-674.10.1016/j.cell.2011.02.013Search in Google Scholar PubMed

[19] Li P, Xue W, Feng Y, Mao Q. Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway, Am J Transl Res, 2016;8:3522-3529.Search in Google Scholar

[20] Chakraborty C, Sharma AR, Patra BC, Bhattacharya M, Sharma G, Lee SS. MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia, Oncotarget, 2016;7:42683-42697.10.18632/oncotarget.7977Search in Google Scholar PubMed PubMed Central

[21] Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases, Biochim. Biophys. Acta, 2010;1802:396-405.10.1016/j.bbadis.2009.12.009Search in Google Scholar

Received: 2018-07-01
Accepted: 2018-11-01
Published Online: 2018-12-31

© 2018 Bin Li et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Research Article
  2. Purification of Tea saponins and Evaluation of its Effect on Alcohol Dehydrogenase Activity
  3. Runt-related transcription factor 3 promoter hypermethylation and gastric cancer risk: A meta-analysis
  4. Risk Factors for Venous Thromboembolism in Hospitalized Patients in the Chinese Population
  5. Value of Dual-energy Lung Perfusion Imaging Using a Dual-source CT System for the Pulmonary Embolism
  6. A new combination of substrates: biogas production and diversity of the methanogenic microorganisms
  7. mTOR modulates CD8+ T cell differentiation in mice with invasive pulmonary aspergillosis
  8. Direct Effects on Seed Germination of 17 Tree Species under Elevated Temperature and CO2 Conditions
  9. Role of water soluble vitamins in the reduction diet of an amateur sportsman
  10. Aberrant DNA methylation involved in obese women with systemic insulin resistance
  11. 16S ribosomal RNA-based gut microbiome composition analysis in infants with breast milk jaundice
  12. Characterization of Haemophilus parasuis Serovar 2 CL120103, a Moderately Virulent Strain in China
  13. MiRNA-145 induces apoptosis in a gallbladder carcinoma cell line by targeting DFF45
  14. Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
  15. Optimizing the Formulation for Ginkgolide B Solid Dispersion
  16. Determination of the In Vitro Gas Production and Potential Feed Value of Olive, Mulberry and Sour Orange Tree Leaves
  17. Factors Influencing the Successful Isolation and Expansion of Aging Human Mesenchymal Stem Cells
  18. The Value of Diffusion-Weighted Magnetic Resonance Imaging in Predicting the Efficacy of Radiation and Chemotherapy in Cervical Cancer
  19. Chemical profile and antioxidant activity of Trollius europaeus under the influence of feeding aphids
  20. SSR Markers Suitable for Marker Assisted Selection in Sunflower for Downy Mildew Resistance
  21. A Fibroblast Growth Factor Antagonist Peptide Inhibits Breast Cancer in BALB/c Mice
  22. Antihyperglycemic and antihyperlipidemic effects of low-molecular-weight carrageenan in rats
  23. Microbial indicators and environmental relationships in the Umhlangane River, Durban, South Africa
  24. TUFT1 promotes osteosarcoma cell proliferation and predicts poor prognosis in osteosarcoma patients
  25. Long non-coding RNA-2271 promotes osteogenic differentiation in human bone marrow stem cells
  26. The prediction of cardiac events in patients with acute ST segment elevation myocardial infarction: A meta–analysis of serum uric acid
  27. Risk expansion of Cr through amphibious clonal plant from polluted aquatic to terrestrial habitats
  28. Overexpression of Zinc Finger Transcription Factor ZAT6 Enhances Salt Tolerance
  29. Sini decoction intervention on atherosclerosis via PPARγ-LXRα-ABCA1 pathway in rabbits
  30. Soluble myeloid triggering receptor expressed on myeloid cell 1 might have more diagnostic value for bacterial ascites than C-reactive protein
  31. A Preliminary Study on the Newly Isolated High Laccase-producing Fungi: Screening, Strain Characteristics and Induction of Laccase Production
  32. Hydrolytic Enzyme Production by Thermophilic Bacteria Isolated from Saudi Hot Springs
  33. Analysis of physiological parameters of Desulfovibrio strains from individuals with colitis
  34. Emodin promotes apoptosis of human endometrial cancer through regulating the MAPK and PI3K/ AKT pathways
  35. Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer
  36. Inhibitory activities of ethanolic extracts of two macrofungi against eggs and miracidia of Fasciola spp.
  37. PAQR6 expression enhancement suggests a worse prognosis in prostate cancer patients
  38. Characterization of a potential ripening regulator, SlNAC3, from Solanum lycopersicum
  39. Expression of Angiopoietin and VEGF in cervical cancer and its clinical significance
  40. Umbilical Cord Tissue Derived Mesenchymal Stem Cells Can Differentiate into Skin Cells
  41. Isolation and Characterization of a Phage to Control Vancomycin Resistant Enterococcus faecium
  42. Glycogen Phosphorylase Isoenzyme Bb, Myoglobin and BNP in ANT-Induced Cardiotoxicity
  43. BAG2 overexpression correlates with growth and poor prognosis of esophageal squamous cell carcinoma
  44. Relationship between climate trends and grassland yield across contrasting European locations
  45. Review Articles
  46. Mechanisms of salt tolerance in halophytes: current understanding and recent advances
  47. Salivary protein roles in oral health and as predictors of caries risk
  48. Nanoparticles as carriers of proteins, peptides and other therapeutic molecules
  49. Survival mechanisms to selective pressures and implications
  50. Up-regulation of key glycolysis proteins in cancer development
  51. Communications
  52. In vitro plant regeneration of Zenia insignis Chun
  53. DNA barcoding of online herbal supplements: crowd-sourcing pharmacovigilance in high school
  54. Case Reports
  55. Management of myasthenia gravis during pregnancy: A report of eight cases
  56. Three Cases of Extranodal Rosai-Dorfman Disease and Literature Review
  57. Letters to the Editor
  58. First report of Chlamydia psittaci seroprevalence in black-headed gulls (Larus ridibundus) at Dianchi Lake, China
  59. Special Issue on Agricultural and Biological Sciences - Part II
  60. Chemical composition of essential oil in Mosla chinensis Maxim cv. Jiangxiangru and its inhibitory effect on Staphylococcus aureus biofilm formation
  61. Secondary metabolites of Antarctic fungi antagonistic to aquatic pathogenic bacteria
  62. Study of Seizure-Manifested Hartnup Disorder Case Induced by Novel Mutations in SLC6A19
  63. Transcriptome analysis of Pinus massoniana Lamb. microstrobili during sexual reversal
  64. Mechanism of oxymatrine-induced human esophageal cancer cell apoptosis by the endoplasmic reticulum stress pathway
  65. Methylation pattern polymorphism of cyp19a in Nile tilapia and hybrids
  66. A Method of Biomedical Information Classification based on Particle Swarm Optimization with Inertia Weight and Mutation
  67. A novel TNNI3 gene mutation (c.235C>T/ p.Arg79Cys) found in a thirty-eight-year-old women with hypertrophic cardiomyopathy
  68. Remote Sensing-Based Extraction and Analysis of Temporal and Spatial Variations of Winter Wheat Planting Areas in the Henan Province of China
  69. Topical Issue on Precision Medicine
  70. Serum sTREM-1, PCT, CRP, Lac as biomarkers for death risk within 28 days in patients with severe sepsis
  71. IL-17 gene rs3748067 C>T polymorphism and gastric cancer risk: A meta-analysis
  72. Efficacy of Danhong injection on serum concentration of TNF-α, IL-6 and NF-κB in rats with intracerebral hemorrhage
  73. An ensemble method to predict target genes and pathways in uveal melanoma
  74. Evaluation of the quality of CT images acquired with smart metal artifact reduction software
  75. NPM1A in plasma is a potential prognostic biomarker in acute myeloid leukemia
  76. Arterial infusion of rapamycin in the treatment of rabbit hepatocellular carcinoma to improve the effect of TACE
  77. New progress in understanding the cellular mechanisms of anti-arrhythmic drugs
https://doi.org/10.1515/biol-2018-0061
Keywords for this article
PAQR6; Kaplan-Meier analysis; proliferation; migration; MAPK signaling pathway
Creative Commons
BY-NC-ND 4.0

Articles in the same Issue

  1. Research Article
  2. Purification of Tea saponins and Evaluation of its Effect on Alcohol Dehydrogenase Activity
  3. Runt-related transcription factor 3 promoter hypermethylation and gastric cancer risk: A meta-analysis
  4. Risk Factors for Venous Thromboembolism in Hospitalized Patients in the Chinese Population
  5. Value of Dual-energy Lung Perfusion Imaging Using a Dual-source CT System for the Pulmonary Embolism
  6. A new combination of substrates: biogas production and diversity of the methanogenic microorganisms
  7. mTOR modulates CD8+ T cell differentiation in mice with invasive pulmonary aspergillosis
  8. Direct Effects on Seed Germination of 17 Tree Species under Elevated Temperature and CO2 Conditions
  9. Role of water soluble vitamins in the reduction diet of an amateur sportsman
  10. Aberrant DNA methylation involved in obese women with systemic insulin resistance
  11. 16S ribosomal RNA-based gut microbiome composition analysis in infants with breast milk jaundice
  12. Characterization of Haemophilus parasuis Serovar 2 CL120103, a Moderately Virulent Strain in China
  13. MiRNA-145 induces apoptosis in a gallbladder carcinoma cell line by targeting DFF45
  14. Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
  15. Optimizing the Formulation for Ginkgolide B Solid Dispersion
  16. Determination of the In Vitro Gas Production and Potential Feed Value of Olive, Mulberry and Sour Orange Tree Leaves
  17. Factors Influencing the Successful Isolation and Expansion of Aging Human Mesenchymal Stem Cells
  18. The Value of Diffusion-Weighted Magnetic Resonance Imaging in Predicting the Efficacy of Radiation and Chemotherapy in Cervical Cancer
  19. Chemical profile and antioxidant activity of Trollius europaeus under the influence of feeding aphids
  20. SSR Markers Suitable for Marker Assisted Selection in Sunflower for Downy Mildew Resistance
  21. A Fibroblast Growth Factor Antagonist Peptide Inhibits Breast Cancer in BALB/c Mice
  22. Antihyperglycemic and antihyperlipidemic effects of low-molecular-weight carrageenan in rats
  23. Microbial indicators and environmental relationships in the Umhlangane River, Durban, South Africa
  24. TUFT1 promotes osteosarcoma cell proliferation and predicts poor prognosis in osteosarcoma patients
  25. Long non-coding RNA-2271 promotes osteogenic differentiation in human bone marrow stem cells
  26. The prediction of cardiac events in patients with acute ST segment elevation myocardial infarction: A meta–analysis of serum uric acid
  27. Risk expansion of Cr through amphibious clonal plant from polluted aquatic to terrestrial habitats
  28. Overexpression of Zinc Finger Transcription Factor ZAT6 Enhances Salt Tolerance
  29. Sini decoction intervention on atherosclerosis via PPARγ-LXRα-ABCA1 pathway in rabbits
  30. Soluble myeloid triggering receptor expressed on myeloid cell 1 might have more diagnostic value for bacterial ascites than C-reactive protein
  31. A Preliminary Study on the Newly Isolated High Laccase-producing Fungi: Screening, Strain Characteristics and Induction of Laccase Production
  32. Hydrolytic Enzyme Production by Thermophilic Bacteria Isolated from Saudi Hot Springs
  33. Analysis of physiological parameters of Desulfovibrio strains from individuals with colitis
  34. Emodin promotes apoptosis of human endometrial cancer through regulating the MAPK and PI3K/ AKT pathways
  35. Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer
  36. Inhibitory activities of ethanolic extracts of two macrofungi against eggs and miracidia of Fasciola spp.
  37. PAQR6 expression enhancement suggests a worse prognosis in prostate cancer patients
  38. Characterization of a potential ripening regulator, SlNAC3, from Solanum lycopersicum
  39. Expression of Angiopoietin and VEGF in cervical cancer and its clinical significance
  40. Umbilical Cord Tissue Derived Mesenchymal Stem Cells Can Differentiate into Skin Cells
  41. Isolation and Characterization of a Phage to Control Vancomycin Resistant Enterococcus faecium
  42. Glycogen Phosphorylase Isoenzyme Bb, Myoglobin and BNP in ANT-Induced Cardiotoxicity
  43. BAG2 overexpression correlates with growth and poor prognosis of esophageal squamous cell carcinoma
  44. Relationship between climate trends and grassland yield across contrasting European locations
  45. Review Articles
  46. Mechanisms of salt tolerance in halophytes: current understanding and recent advances
  47. Salivary protein roles in oral health and as predictors of caries risk
  48. Nanoparticles as carriers of proteins, peptides and other therapeutic molecules
  49. Survival mechanisms to selective pressures and implications
  50. Up-regulation of key glycolysis proteins in cancer development
  51. Communications
  52. In vitro plant regeneration of Zenia insignis Chun
  53. DNA barcoding of online herbal supplements: crowd-sourcing pharmacovigilance in high school
  54. Case Reports
  55. Management of myasthenia gravis during pregnancy: A report of eight cases
  56. Three Cases of Extranodal Rosai-Dorfman Disease and Literature Review
  57. Letters to the Editor
  58. First report of Chlamydia psittaci seroprevalence in black-headed gulls (Larus ridibundus) at Dianchi Lake, China
  59. Special Issue on Agricultural and Biological Sciences - Part II
  60. Chemical composition of essential oil in Mosla chinensis Maxim cv. Jiangxiangru and its inhibitory effect on Staphylococcus aureus biofilm formation
  61. Secondary metabolites of Antarctic fungi antagonistic to aquatic pathogenic bacteria
  62. Study of Seizure-Manifested Hartnup Disorder Case Induced by Novel Mutations in SLC6A19
  63. Transcriptome analysis of Pinus massoniana Lamb. microstrobili during sexual reversal
  64. Mechanism of oxymatrine-induced human esophageal cancer cell apoptosis by the endoplasmic reticulum stress pathway
  65. Methylation pattern polymorphism of cyp19a in Nile tilapia and hybrids
  66. A Method of Biomedical Information Classification based on Particle Swarm Optimization with Inertia Weight and Mutation
  67. A novel TNNI3 gene mutation (c.235C>T/ p.Arg79Cys) found in a thirty-eight-year-old women with hypertrophic cardiomyopathy
  68. Remote Sensing-Based Extraction and Analysis of Temporal and Spatial Variations of Winter Wheat Planting Areas in the Henan Province of China
  69. Topical Issue on Precision Medicine
  70. Serum sTREM-1, PCT, CRP, Lac as biomarkers for death risk within 28 days in patients with severe sepsis
  71. IL-17 gene rs3748067 C>T polymorphism and gastric cancer risk: A meta-analysis
  72. Efficacy of Danhong injection on serum concentration of TNF-α, IL-6 and NF-κB in rats with intracerebral hemorrhage
  73. An ensemble method to predict target genes and pathways in uveal melanoma
  74. Evaluation of the quality of CT images acquired with smart metal artifact reduction software
  75. NPM1A in plasma is a potential prognostic biomarker in acute myeloid leukemia
  76. Arterial infusion of rapamycin in the treatment of rabbit hepatocellular carcinoma to improve the effect of TACE
  77. New progress in understanding the cellular mechanisms of anti-arrhythmic drugs
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Winner of the OpenAthens UX Award 2026
Winner of the OpenAthens UX Award 2026
Have an idea on how to improve our website?
Please write us.
© 2026 De Gruyter Brill
Downloaded on 1.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2018-0061/html
Scroll to top button